l-Alanyl-Glutamine Preoperative Infusion in Patients with Critical Limb Ischemia Subjected to Distal Revascularization Reduces Tissue Damage and Protects from Oxidative Stress

Annals of Vascular Surgery

Volumn 24, Issue 4, 2010, Pages 461-467

  Alves, Wellington Forte ^a   Aguiar, Erika Elisa ^a   Guimarães, Sergio Botelho ^b   da Silva Filho, Antonio Ribeiro ^c   Pinheiro, Petrúcia Maria Antero ^a,b   Soares, Gabriel dos Santos Dias ^b   de Vasconcelos, Paulo Roberto Leitão ^b  

^a General Hospital of Fortaleza   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c CENTRO UNIVERSITÁRIO UNICHRISTUS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLUTAMINE; CREATINE KINASE; GLUTATHIONE; LACTATE DEHYDROGENASE; LACTIC ACID; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTERY BYPASS; ARTICLE; BLOOD ANALYSIS; CELL DAMAGE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; FEMALE; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HUMAN; HUMAN TISSUE; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LEG ISCHEMIA; LEG REVASCULARIZATION; LIMB BLOOD FLOW; LIPID PEROXIDATION; MALE; METABOLITE; MUSCLE LEVEL; OXIDATIVE STRESS; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPERFUSION; TISSUE INJURY;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BRAZIL; CREATINE KINASE; CRITICAL ILLNESS; DIPEPTIDES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUTATHIONE; HUMANS; INFUSIONS, INTRAVENOUS; ISCHEMIA; L-LACTATE DEHYDROGENASE; LACTIC ACID; LIPID PEROXIDATION; LOWER EXTREMITY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXIDATIVE STRESS; PREOPERATIVE CARE; REGIONAL BLOOD FLOW; SAPHENOUS VEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951665462     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2010.01.005     Document Type: Article

References (15)

1. Hughes K., Domenig C.M., Hamdan A.D., et al. Bypass to plantar and tarsal arteries: an acceptable approach to limb salvage. J Vasc Surg 40 (2004) 1149-1157
2. Wehrens X.H., Rouwet E.V., Egbrink M.G., et al. Effects of experimental lower-limb ischaemia/reperfusion injury on the mesenteric microcirculation. Br J Surg 89 (2002) 185-191
3. Furst P., Pogan K., and Stehle P. Glutamine dipeptides in clinical nutrition. Nutrition 13 (1997) 731-737
4. Amador E., Dorfman L.E., and Wacker W.E. Serum lactic dehydrogenase activity: an analytical assessment of current assays. Clin Chem 12 (1963) 391-399
5. Mathieu M., and Maire I. Modification of a recommended method for the determination of catalytic concentration of creatine kinase in human serum at 30 degrees C (document C', stage 3). Ann Biol Clin (Paris) 38 (1980) 191-197
6. Hohorst H.J. D-Glucose-6-phosphate and D-fructose-6-phosphate. Determination with glucose-6-phosphate dehydrogenase and phosphoglucose isomerase. In: Bergmeyer H.-U. (Ed). Methods of Enzymatic Analysis (1963), Verlag Chemie, Weinheim/Academic Press, New York/London 134-138
7. Sedlak J., and Lindsay R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25 (1968) 192-205
8. Mathews D.E. Glutamine and glutamate kinetics in humans. Pharmacological Nutrition. Immune Nutrition (1995), W. Zuckschwerdt Verlag, New York 68-76
9. Garlick P.J. Assessment of the safety of glutamine and other amino acids. J Nutr 131 (2001) 2556S-2561S
10. Ziegler T.R., Benfell K., Smith R.J., et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN J. Parenter Enteral Nutr 14 (1990) 137S-46S
11. Bakalar B., Duska F., Pachl J., et al. Parenterally administered dipeptide alanylglutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 34 (2006) 381-386
12. Prem J.T., Eppinger M., Lemmon G., et al. The role of glutamine in skeletal muscle ischemia/reperfusion injury in the rat hind limb model. Am J Surg 178 (1999) 147-150
13. Annetta M.G., Ciancia M., Soave M., et al. Diabetic and nondiabetic hyperglycemia in the ICU. Curr Anaesth Crit Care 17 (2006) 385-390
14. Dechelotte P., Hasselmann M., Cynober L., et al. L-Alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 34 (2006) 598-604
15. Alves M.A., Guimarães S.B., Dias D.A., de Vasconcelos P.R.C., Coelho V.P.M., and de Vasconcelos P.R.L. Effects of L-alanyl-glutamine upon the blood and kidney biochemical parameters in the rat hind limb model of ischemia/reperfusion. Acta Circ Bras 20 (2005) 445-449